Seikagaku Corporation (TYO:4548)
Japan · Delayed Price · Currency is JPY 639.00
+14.00 (2.24%)
Jul 18, 2025, 3:30 PM JST
Seikagaku Revenue
In the fiscal year ending March 31, 2025, Seikagaku had annual revenue of 39.37B JPY with 8.73% growth. Seikagaku had revenue of 8.93B in the quarter ending March 31, 2025, with 1.13% growth.
Revenue
39.37B
Revenue Growth
+8.73%
P/S Ratio
0.87
Revenue / Employee
36.63M
Employees
1,075
Market Cap
34.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 39.37B | 3.16B | 8.73% |
| Mar 31, 2024 | 36.21B | 2.76B | 8.24% |
| Mar 31, 2023 | 33.46B | -1.40B | -4.00% |
| Mar 31, 2022 | 34.85B | 7.19B | 25.99% |
| Mar 31, 2021 | 27.66B | -980.00M | -3.42% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 866.03B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.27B |